glutamine and Parkinson Disease, Secondary

glutamine has been researched along with Parkinson Disease, Secondary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Ağar, A; Akçay, G; Aydın Aslan, M; Bülbül, M; Derin, N; Özkan, A; Parlak, H; Sinen, O1
Fang, F; Fang, K; Hou, Z; Lei, H; Lin, X; Liu, M; Liu, S; Meng, H; Sun, B; Zhang, Z1
Fukuda, R; Fukui, T; Iwanami, A; Kasai, K; Kato, N; Kato, T; Yamasue, H1
Gründig, E; Raheem, KA; Salvenmoser, F; Schedl, R; Weiss, J1

Other Studies

4 other study(ies) available for glutamine and Parkinson Disease, Secondary

ArticleYear
Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson’s disease
    Turkish journal of medical sciences, 2021, 12-13, Volume: 51, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cognition; Depression; Disease Models, Animal; Dopamine; Glutamic Acid; Glutamine; Mice; Mice, Inbred C57BL; Neuropeptides; Neuroprotective Agents; Parkinson Disease, Secondary

2021
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.
    The International journal of neuroscience, 2014, Volume: 124, Issue:2

    Topics: Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Frontal Lobe; Functional Laterality; Functional Neuroimaging; Glutamates; Glutamic Acid; Glutamine; Magnetic Resonance Spectroscopy; Male; Motor Activity; Oxidopamine; Parietal Lobe; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors

2014
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:4

    Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creatine; Dominance, Cerebral; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Phosphocreatine; Putamen; Reference Values; Schizophrenia; Schizophrenic Psychology

2003
Drug-induced parkinsonism in the rat- a model for biochemical investigation of the parkinson-syndrome. III. The incorporation of D-glucose-14C(U) in amino acids of brain and liver from rats pretreated with reserpine or with phenothiazines.
    Psychopharmacology, 1976, May-05, Volume: 47, Issue:1

    Topics: Amino Acids; Animals; Antipsychotic Agents; Brain; Glucose; Glutamates; Glutamine; Glycine; Liver; Male; Parkinson Disease, Secondary; Phenothiazines; Rats; Reserpine; Serine

1976